Patents by Inventor Méabh Brennan

Méabh Brennan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinoline compounds
    Patent number: 9822078
    Abstract: The present invention relates to quinoline compounds as defined by Formula I below. Such quinoline compounds have been shown to inhibit the formation of amyloid deposits (e.g., amyloid oligomers, fibrils or plaques). Consequently, these compounds are suitable for treating a range of diseases and disorders in which amyloid deposits are implicated, such as type-2 diabetes and Alzheimer's disease.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: November 21, 2017
    Assignee: Oxford University Innovation Limited
    Inventors: David Vaux, Letitia Jean, Stephen Davies, Angela Russell, Graham Wynne, Carole Bataille, Méabh Brennan
  • QUINOLINE COMPOUNDS
    Publication number: 20170008849
    Abstract: The present invention relates to quinoline compounds as defined by Formula I below. Such quinoline compounds have been shown to inhibit the formation of amyloid deposits (e.g., amyloid oligomers, fibrils or plaques). Consequently, these compounds are suitable for treating a range of diseases and disorders in which amyloid deposits are implicated, such as type-2 diabetes and Alzheimer's disease.
    Type: Application
    Filed: February 27, 2015
    Publication date: January 12, 2017
    Inventors: David Vaux, Letitia Dean, Stephen Davies, Angela Russell, Graham Wynne, Carole Bataille, Méabh Brennan